Somaiya Mayur Ian
Insider CIK 1760303 · TCRR Chief Financial Officer · NAMS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2026-01-21 | 2026-01-22 | 39,784 | — | $0 | 662,814 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2026-01-21 | 2026-01-22 | 39,784 | $9.26 | $368.4K | 98,166 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-21 | 2026-01-22 | 15,422 | $33.25 | $512.8K | 82,744 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-21 | 2026-01-22 | 24,362 | $33.80 | $823.4K | 58,382 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2026-01-20 | 2026-01-22 | 60,216 | — | $0 | 702,598 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-20 | 2026-01-22 | 900 | $30.64 | $27.6K | 117,698 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-20 | 2026-01-22 | 39,712 | $31.78 | $1.26M | 77,986 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-20 | 2026-01-22 | 19,604 | $32.38 | $634.8K | 58,382 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2026-01-20 | 2026-01-22 | 60,216 | $9.26 | $557.6K | 118,598 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2026-01-07 | 2026-01-07 | 115,000 | — | $0 | 115,000 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award | 2026-01-07 | 2026-01-07 | 25,500 | — | $0 | 58,382 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-01-05 | 2026-01-07 | 5,118 | $33.25 | $170.2K | 32,882 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-01-28 | 2025-01-29 | 14,900 | — | $0 | 762,814 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-01-28 | 2025-01-29 | 14,900 | $9.26 | $138.0K | 52,900 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2025-01-28 | 2025-01-29 | 11,495 | — | $0 | 41,405 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2025-01-28 | 2025-01-29 | 3,405 | — | $0 | 38,000 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-01-27 | 2025-01-29 | 46,983 | — | $0 | 777,714 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2025-01-27 | 2025-01-29 | 33,679 | — | $0 | 51,304 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-01-27 | 2025-01-29 | 46,983 | $9.26 | $435.1K | 84,983 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2025-01-27 | 2025-01-29 | 13,304 | — | $0 | 38,000 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award | 2025-01-07 | 2025-01-07 | 38,000 | — | $0 | 38,000 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2025-01-02 | 2025-01-06 | 220,000 | — | $0 | 220,000 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2024-01-01 | 2024-01-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2020-12-14 | 2020-12-16 | 2,000 | — | $0 | 102,558 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2020-12-14 | 2020-12-16 | 2,000 | $5.88 | $11.8K | 3,473 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-12-14 | 2020-12-16 | 2,000 | $35.00 | $70.0K | 1,473 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2020-12-10 | 2020-12-11 | 92,000 | — | $0 | 92,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2020-11-17 | 2020-11-19 | 2,000 | — | $0 | 104,558 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-11-17 | 2020-11-19 | 1,666 | $30.00 | $50.0K | 1,473 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2020-11-17 | 2020-11-19 | 2,000 | $5.88 | $11.8K | 5,139 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-11-17 | 2020-11-19 | 2,000 | $30.00 | $60.0K | 3,139 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2020-02-28 | 2020-03-27 | 1,473 | $10.10 | $14.9K | 3,139 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-12-19 | 2019-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2019-08-30 | 2020-03-27 | 1,666 | $12.75 | $21.2K | 1,666 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-04-11 | 2019-04-12 | 152,307 | — | $0 | 152,307 | SEC↗ |